Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carrascosa

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Dermatologic Therapy|September 29, 2022
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis GroupVicenç Rocamora, Laura Crespi, Marta Ferran, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2012
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registryA I Sánchez-Moya, I García-Doval, G Carretero, et al.
Molecular Metabolism|April 4, 2020
Impact of global PTP1B deficiency on the gut barrier permeability during NASH in miceCarmen Rubio, Marta Puerto, Juan J García-Rodríquez, et al.
Actas Dermo-Sifiliograficas|July 16, 2017
Guidelines on the Use of Methotrexate in PsoriasisG Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]G Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|October 16, 2020
Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus StatementI Belinchón, M Velasco, M Ara-Martín, et al.
The Journal of Dermatological Treatment|November 4, 2017
Redefining the therapeutic objective in psoriatic patients candidates for biological therapyG Carretero, L Puig, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|July 5, 2015
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over timeJ M Carrascosa, N Rivera, I Garcia-Doval, et al.
Acta Dermato-Venereologica|March 29, 2023
Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care PhysiciansEmilio Berna-Rico, Carlota Abbad-Jaime de Aragon, Angel Garcia-Aparicio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2014
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registryG Carretero, C Ferrandiz, E Dauden, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Dermatologic Therapy|September 29, 2022
Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis GroupVicenç Rocamora, Laura Crespi, Marta Ferran, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2012
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registryA I Sánchez-Moya, I García-Doval, G Carretero, et al.
Molecular Metabolism|April 4, 2020
Impact of global PTP1B deficiency on the gut barrier permeability during NASH in miceCarmen Rubio, Marta Puerto, Juan J García-Rodríquez, et al.
Actas Dermo-Sifiliograficas|July 16, 2017
Guidelines on the Use of Methotrexate in PsoriasisG Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|September 23, 2010
[Guidelines on the use of methotrexate in psoriasis]G Carretero, L Puig, L Dehesa, et al.
Actas Dermo-Sifiliograficas|October 16, 2020
Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus StatementI Belinchón, M Velasco, M Ara-Martín, et al.
The Journal of Dermatological Treatment|November 4, 2017
Redefining the therapeutic objective in psoriatic patients candidates for biological therapyG Carretero, L Puig, J M Carrascosa, et al.
Actas Dermo-Sifiliograficas|July 5, 2015
Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over timeJ M Carrascosa, N Rivera, I Garcia-Doval, et al.
Acta Dermato-Venereologica|March 29, 2023
Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care PhysiciansEmilio Berna-Rico, Carlota Abbad-Jaime de Aragon, Angel Garcia-Aparicio, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2014
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registryG Carretero, C Ferrandiz, E Dauden, et al.
Pageof 25